China’s experimental vaccine trial approved in Bangladesh
Published: 01:55 PM, 24 June 2021 Updated: 08:12 PM, 24 June 2021
The Bangladesh Medical Research Council (BMRC) has approved the experimental trial of the China-invented coronavirus vaccine.
The International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) was allowed to trial the vaccine on Wednesday.
The new vaccine was developed by China’s Institute of Medical Biology of the Chinese Academy of Medical Sciences. In short, it is called IMB Campus.
Earlier, China’s Sinovac Biotech wanted to trial their Covid-19 vaccine in Bangladesh; One year after that, another vaccine from the country was allowed for a human trial.